Exile Group welcomes Bridgepoint, a leading mid-market investor, which will take a minority interest in the leading provider of events and intelligence for the export,...
Cooperation, transparency and governance are not new buzzwords in the development, export and project finance space. These words echo like a mantra through an editorial...
Welcome to Exiled: The Real Assets People, a podcast where we ‘strand’ a guest on a desert island and ask them who from their professional past, present, and future...
Biovac’s EU-backed quasi-equity package and Brazil’s planned $1.2 billion vaccine PPP suggest that life-sciences are increasingly viewed as social infrastructure. But even vaccine sovereignty is hard to bank without public risk-sharing, demand visibility and unusually credible developers.